SCHEDULE: Vanguard Reports 3.59% Stake in Journey Medical Corp

Vanguard Capital Management has disclosed a beneficial ownership of 774,556 shares, representing 3.59% of the outstanding common stock of Journey Medical Corp.

Summary

• Vanguard Capital Management, through its affiliates and managed accounts, now beneficially owns 774,556 shares of Journey Medical Corp. common stock.
• This holding represents 3.59% of the total class of securities.
• Vanguard has sole voting power over 99,371 shares and sole dispositive power over all 774,556 shares.
• The filing is an amendment (Amendment No. 1) to a previous Schedule 13G filing.
• The reporting entity, Vanguard Capital Management, is an investment adviser.
• The filing certifies that the securities were acquired and are held in the ordinary course of business and not for the purpose of influencing control of the issuer.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing. It represents a standard disclosure of institutional ownership by a major asset manager and does not inherently signal positive or negative performance for the company itself.

Positives

• Vanguard Capital Management, a significant institutional investor, has taken a notable stake in Journey Medical Corp., which could be interpreted as a sign of confidence in the company's prospects.
• The filing confirms Vanguard's sole dispositive power over the shares, indicating clear control over investment decisions for these holdings.

Negatives

• The filing does not contain any negative financial results or operational challenges for Journey Medical Corp. itself, as it is a disclosure of ownership by an external entity.

Risks

• The filing does not explicitly mention any risks related to Journey Medical Corp.'s business operations or financial health. The primary risk associated with this type of filing is the potential for significant institutional investors to alter their holdings, which could impact share price.

Future Outlook

The filing itself does not provide a future outlook for Journey Medical Corp. It is a disclosure of ownership by Vanguard Capital Management.

Management Comments

• "In accordance with SEC Release No. 34-39538 (January 12, 1998), this Schedule 13G reflects the securities beneficially owned, or deemed to be beneficially owned, by Vanguard Capital Management LLC and the following affiliates of Vanguard Capital Management LLC or business divisions of such affiliates: Vanguard Asset Management Limited, Vanguard Fiduciary Trust Company, Vanguard Global Advisers, LLC and Vanguard Investments Australia Ltd."
• "This Schedule 13G includes securities held by Vanguard funds, or sleeves thereof, over which Vanguard Capital Management LLC exercises dispositive power, in addition to securities held by clients over which the affiliates or business divisions of such affiliates indicated above exercise dispositive and/or voting power."
• "This Schedule 13G does not include securities, if any, beneficially owned by other subsidiaries or affiliates of Vanguard Capital Management LLC, or business divisions of such subsidiaries, whose ownership of securities is disaggregated from that of the reporting business unit in accordance with such release."
• "By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under 240.14a-11."

Industry Context

StockSavvy.ai notes that a Schedule 13G filing by a major asset manager like Vanguard indicates a passive investment stake, typically held by index funds or diversified portfolios, rather than an activist position. This suggests Vanguard views Journey Medical Corp. as a component within broader market indices or diversified investment strategies.

Stakeholder Impact

• Shareholders: The increased visibility of a significant institutional holder like Vanguard may attract further investor interest, potentially influencing share price. However, Vanguard's passive stake suggests no immediate change in corporate control or strategy.
• Management: The filing does not directly impact management, but it confirms the company is part of diversified investment portfolios.
• Creditors: No direct impact on creditors is indicated by this filing.

Next Steps

• Vanguard Capital Management will continue to hold or manage its stake in Journey Medical Corp. according to its investment strategies.
• Journey Medical Corp. will continue its business operations as usual, subject to market conditions and its own strategic initiatives.

Key Dates

Keywords

Journey Medical Corp, Vanguard Capital Management, Schedule 13G, Beneficial Ownership, Common Stock, Investment Adviser, Institutional Investor, Shareholder Disclosure